Evident Vascular, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident Vascular® Guidance System and Evident® peripheral imaging catheters. The Evident Vascular Guidance System is intended for ultrasound examination of intravascular pathology during peripheral vascular interventions.
Funding to accelerate development of next-generation intravascular ultrasound platform and support FDA clearance for U.S. market launch San Jose, CA – March 25, 2025 – Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence, today announced the successful closing of its Series B financing with new […]
San Jose, CA – January 7, 2025 – Evident Vascular Inc., a medical technology startup backed by Vensana Capital® developing an AI-powered next-generation intravascular ultrasound (IVUS) platform, is pleased to announce the appointment of Scott R. Ward to its Board of Directors. With over 40 years of leadership in healthcare and medical technology, Mr. Ward […]
Scientific Advisory Board includes clinical experts in interventional cardiology, interventional radiology and vascular surgery. Bruce Shook, seasoned medtech executive and entrepreneur, joins Board of Directors.
Evident Vascular™ Inc., a medical technology startup developing a next-generation intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, announced today that it has launched with a $35 million Series A financing from Vensana Capital.
